Testopel
Product Images NDC 43773-1001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Testopel (NDC 43773-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Stucture (28c87785 4554 4172 9b11 F6a9d72923a8 01)

Chemical structure of testosterone shown with its molecular formula C19H28O2, molecular weight 288.43, and chemical name 17ß-Hydroxyandrost-4-en-3-one. The diagram depicts the steroid nucleus with hydroxyl and ketone functional groups.*

FDA Label Image

Testopel (testosterone Pellets) Label (28c87785 4554 4172 9b11 F6a9d72923a8 02)

Packaging label for Testopel 75 mg testosterone pellets sterile, containing 100 pellets for subcutaneous implantation. The label indicates each pellet contains 75 mg testosterone, with inactive ingredients including stearic acid and polyvinylpyrrolidone USP 2 mg. Marketed by Slate Pharmaceuticals, manufactured by Bartor Pharmacal.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.